It is also known that GMF is up-regulated in the central nervous system in neuro-degenerative diseases, such as Alzheimer's disease [12, 13], suggesting that GMF overexpression in brain tissue might play important roles in the pathogenesis of these neurodegenerative diseases [10–13]. Here, GMFB is linked to early-onset autosomal dominant Alzheimer disease.